Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01868776 · ClinicalTrials.gov registry record · NA
Effect of Buffered Numbing Solution on Patients With Toothaches
A NA study of Irreversible Pulpitis (Toothache), sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT01868776: Completed NA study of Irreversible Pulpitis (Toothache), sponsored by Ohio State University.
NCT01868776 is a NA study of Irreversible Pulpitis (Toothache) that has completed, run by Ohio State University. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01868776, a NA study of Irreversible Pulpitis (Toothache), has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the effect of buffered lidocaine (a numbing solution) on the ability to numb patients with toothaches. Buffered anesthetic (numbing) solutions have shown promise in some medical and dental research. Patients presenting with toothaches will be given either a buffered numbing solution or a nonbuffered numbing solution. Neither the patient nor the operator will know which solution they will receive. Root canal treatment will be performed on the tooth and the ability of the buffered versus non-buffered numbing solutions will be compared.
Conditions Studied
Interventions
- DRUG buffered lidocaine
- DRUG nonbuffered lidocaine
Study Locations (1)
Ohio
- The Ohio State University College of Dentistry, Postle Hall - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2013-03 |
| Est. Completion | 2013-12 |
| Phase | NA |
What the finished NCT01868776 record still lists
NCT01868776 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Irreversible Pulpitis (Toothache) appearing as the primary indexed condition, and to 2 interventions - of which buffered lidocaine is the first listed.
NCT01868776 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01868776 about?
NCT01868776 is a clinical study titled "Effect of Buffered Numbing Solution on Patients With Toothaches". The purpose of this study is to determine the effect of buffered lidocaine (a numbing solution) on the ability to numb patients with toothaches. Buffered anesthetic (numbing) solutions have shown promise in some medical and dental research. Patients presenting with toothaches will be given either a ...
What is the current status of trial NCT01868776?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2013-03. Estimated completion is 2013-12.
What conditions does trial NCT01868776 study?
This clinical trial studies the following conditions: Irreversible Pulpitis (Toothache).
What interventions are being tested in trial NCT01868776?
The interventions under investigation include: buffered lidocaine (DRUG), nonbuffered lidocaine (DRUG).
Who is sponsoring clinical trial NCT01868776?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01868776 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01868776's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia